NCT07851077

Brief Summary

HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,900

participants targeted

Target at P75+ for not_applicable hiv

Timeline
43mo left

Started Jan 2028

Typical duration for not_applicable hiv

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 1, 2028

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2031

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

August 26, 2026

Last Update Submit

September 24, 2026

Conditions

Keywords

hivmental healthadolescentssocial media

Outcome Measures

Primary Outcomes (2)

  • Percentage of participants who attend an HIV care visit within 30 days after enrollment

    Linkage to HIV care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.

    Within 30 days after enrollment

  • Percentage of participants who are linked to HIV prevention within 30 days after enrollment

    Linkage to HIV prevention is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.

    Within 30 days after enrollment

Secondary Outcomes (3)

  • Percentage of participants who are linked to mental health care

    Within 30 days after enrollment

  • brief Berger HIV Stigma scale

    Baseline, immediate post, 30 days post

  • Attitudes Toward Seeking Professional Psychological Help Scale-Short Form

    Baseline, immediately post, 30 days post

Other Outcomes (6)

  • Patient Health Questionnaire-9

    baseline

  • Generalized Anxiety Disorder-7

    baseline

  • Posttraumatic stress disorder symptoms

    baseline

  • +3 more other outcomes

Study Arms (2)

intervention group (BVHS)

EXPERIMENTAL

Participants will receive Brief Videos for HIV Stigma (BVHS)

Behavioral: Brief Videos for HIV Stigma

Control

NO INTERVENTION

Participants will receive videos without BVHS

Interventions

Intersectionally-tailored brief videos to reduce public and internalized HIV stigma (BVHS)

intervention group (BVHS)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Psychological Well-BeingAcquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: We will examine efficacy to increase linkage to HIV prevention and treatment and mental health treatment using BVHS vs an attention control. The purpose of the control videos is to present a generic informative video that provides comparable facts but lacks social components that promote identification and emotional engagement. A randomized controlled trial (RCT) will be utilized, with participants randomly assigned to either the intervention group (BVHS) or a control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 26, 2026

First Posted

October 1, 2026

Study Start (Estimated)

January 1, 2028

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2031

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share